All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
5.1 Antibacterial drugs
Toggle Pages
5.1.1 Penicillins
5.1.2 Cephalosporins, carbapenems, and other beta-lactams
5.1.3 Tetracyclines
5.1.4 Aminoglycosides
5.1.5 Macrolides
5.1.6 Clindamycin
5.1.7 Some other antibacterials
5.1.8 Sulfonamides and trimethoprim
5.1.9 Antituberculosis drugs
5.1.10 Antileprotic drugs
5.1.11 Nitroimidazole derivatives
5.1.12 Quinolones
5.1.13 Urinary-tract infections
Chapter 5: Infections
Toggle Parent Pages
Print this page
Principles of antibacterial treatment
Upper respiratory tract infections
Lower respiratory tract infections
Acute exacerbation of bronchiectasis (non-cystic fibrosis)
Urinary tract infections (UTI)
Gastro-intestinal tract infections
Genital tract infections
Skin and soft tissue infections
Eye infections
Oral and dental infections
Lyme disease guidance
Meningitis guidance
Methicillin Resistant Staphylococcus Aureus (MRSA) guidance
COVID-19 treatments for patients who do not require hospitalisation
5.1 Antibacterial drugs
5.2 Antifungal drugs
5.3 Antiviral drugs
5.4 Antiprotozoal drugs
5.5 Anthelmintics
Page last updated:
28 October 2019
Contact us about this page
5.1.10 Antileprotic drugs
First Line
Second Line
Specialist
Hospital Only
Dapsone
- Tablets 50mg, 100mg (£7.16 = 28 x 50mg tablets, £17.94 = 28 x 100mg tablets)
Indications
- Dermatitis herpetiformis and other dermatoses
Notes
